"Innovative Research of West Florida is an experienced medical research company involved in clinical trials for Pharmaceutical or medical device companies. This involves bringing new drugs to market, or validating changes in indication for companies involved with the FDA. Specializing in diagnosis's including but not limited to COPD, Asthma, Atopic Dermatitis, Diabetes, Congestive Heart Failure, Low Testosterone, and Vaccines."

During the past decade, Innovative Research of West Florida, Inc. conducted 100 clinical trials. In the 10-year time frame, 100 clinical trials started and 69 clinical trials were completed, i.e. on average, 69% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 41 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Innovative Research of West Florida, Inc." #1 sponsor was "Pfizer" with 20 trials, followed by "Janssen Research & Development, LLC" with 7 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 7 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 6 trials sponsored and "Purdue Pharma LP" with 6 trials sponsored. Other sponsors include 102 different institutions and companies that sponsored additional 70 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Innovative Research of West Florida, Inc." #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Cardiokine Biopharma, LLC" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Innovative Research of West Florida, Inc." are "Schizophrenia" (16 trials), "Depressive Disorder, Major" (12 trials), "Osteoarthritis" (7 trials), "Gastroparesis" (5 trials) and "Major Depressive Disorder" (5 trials). Many other conditions were trialed in "Innovative Research of West Florida, Inc." in a lesser frequency.

Most popular intervention types in "Innovative Research of West Florida, Inc." are "Drug" (128 trials), "Biological" (19 trials), "Other" (17 trials), "Combination Product" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (80 trials), "placebo" (8 trials), "Rapastinel" (7 trials), "Pregabalin" (3 trials) and "RBP-6000" (3 trials). Other intervention names were less common.

The vast majority of trials in "Innovative Research of West Florida, Inc." are 149 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Innovative Research of West Florida, Inc.". undefined are not yet recruiting, 19 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 98 completed trials in Innovative Research of West Florida, Inc., 1 suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in Innovative Research of West Florida, Inc., 6 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 3 trials that are defined as “Not Applicable".